Key facts
- It has raised $160K; the latest was Seed Round ($150K) in Apr 2025.
- Notable investors include Right Side Capital Management, Halcyon Incubator, Visible Hands.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Jayla
- ·The full record, as it builds
Funding rounds
No funding rounds for Jayla are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jayla
Provider of a tech-enabled care platform designed to support women through perimenopause and menopause with clarity, convenience, and compassion. The company offers at-home hormone testing paired with virtual consultations with trained menopause providers, and an online pharmacy that ships treatments directly to the patient's door, enabling women navigating menopause to receive personalized guidance and care with ease.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 4
- Website
- jaylahealth.com/
- Ownership
- Privately Held (backing)
Jayla doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jayla shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jayla in its N-PORT filings yet. We sweep new filings monthly.